AvantGuard is blurring the line between antibiotics, antiseptics, and disinfectants by pioneering cutting-edge chemistries that have no history of pathogen resistance and are rooted in the body’s natural defenses. Developed by world-leading scientists, our chemistries target and eliminate pathogens and biofilms on the skin, medical devices, and other surfaces.

One of our first objectives is to replace topical antibiotics and preserve their efficacy for when they’re needed most. What could be more important than the ability to protect our skin from infection and invasive diseases without contributing to pathogen resistance?

AvantGuard’s proprietary combinations of specialty molecules provide safe, long lasting, continuous treatment and protection against dangerous pathogens and their biofilms in a variety of applications, ensuring a healthier and safer world, while creating $70B in market opportunities.